Hanseatic Management Services’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-41
Closed -$2K 226
2020
Q2
$2K Hold
41
﹤0.01% 175
2020
Q1
$2K Hold
41
﹤0.01% 189
2019
Q4
$2K Hold
41
﹤0.01% 225
2019
Q3
$1K Hold
41
﹤0.01% 201
2019
Q2
$2K Hold
41
﹤0.01% 197
2019
Q1
$2K Sell
41
-42
-51% -$1.41K ﹤0.01% 249
2018
Q4
$3K Hold
83
﹤0.01% 217
2018
Q3
$4K Hold
83
﹤0.01% 283
2018
Q2
$3K Hold
83
﹤0.01% 290
2018
Q1
$2K Hold
83
﹤0.01% 343
2017
Q4
$1K Sell
83
-22
-21% -$372 ﹤0.01% 390
2017
Q3
$2K Buy
+105
New +$2.06K ﹤0.01% 347
2015
Q2
Sell
-4,300
Closed -$262K 427
2015
Q1
$262K Buy
+4,300
New +$262K 0.14% 155

Other funds holding PTCT

Hanseatic Management Services's PTCT Position: Q3 2020 in Review

Hanseatic Management Services sold out of PTC Therapeutics (PTCT) in Q3 2020, closing a stake of 41 shares — an estimated $2K sold.

Hanseatic Management Services first reported a position in PTCT in Q1 2015 and held it in 13 quarters. The position peaked at $262K in Q1 2015. 196 funds tracked by Wall St. Rank hold PTCT as of Q3 2020.

  • Hanseatic Management Services reported no remaining PTC Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Hanseatic Management Services sold 41 PTC Therapeutics shares in Q3 2020, an estimated $2K.
  • Hanseatic Management Services first reported a position in PTC Therapeutics in Q1 2015 and held it in 13 quarters.
  • Hanseatic Management Services's PTC Therapeutics position peaked at $262K in Q1 2015.
  • 196 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2020.

Based on Hanseatic Management Services's 13F filing for Q3 2020, filed 29 Oct 2020.